Finally, Jurkowska et al. examined BRAF mutations in 236 FFPE cutaneous melanoma lymph node metastases by Sanger sequencing tests and the Cobas® 4800 BRAF V600 Mutation Test. This evidence concerns the gene BRAF and cutaneous melanoma.